USB — U.S. Bancorp

Q2 2026 delivered a clear beat: $1.35 EPS versus $1.27 consensus, record net revenue, 7.7% net interest income growth, 13.2% fee revenue growth, and a 62.5% jump in capital-markets revenue helped by BTIG. The bank also passed the Fed stress test, plans a 4% dividend hike, and raised full-year revenue guidance. Wall Street has responded with upgrades and higher targets, and the stock has returned more than 30% over the past year; the recent pullback to $62.40 looks like consolidation, not a change in sentiment.

The trend is an upward earnings/margin inflection, not a one-quarter blip. Excluding the Q4 2023 FDIC special-assessment distortion, operating income rose for six consecutive quarters, from $2.06B in Q2 2024 to $2.72B in Q2 2026, lifting operating margin from roughly 19.0% to 24.9%. Diluted EPS moved from $0.97 in Q2 2024 to $1.35 in Q2 2026, with Q2 2026 up about 21.6% year over year. The reported revenue line also re-accelerated from $10.53B in Q2 2025 to $10.92B in Q2 2026. Q1 2026's softer EPS and Q1 2025's negative free cash flow look seasonal, not structural.

As of 2026-08-27, USB is fairly valued, not expensive. Trailing P/E of 12.46x is essentially in line with its 5-year average of 12.04x, and forward P/E on $5.22 estimated EPS is about 11.95x. The 0.63 PEG is flattering if you assume high-teens to 20% growth, but even under a more conservative 10-13% EPS growth scenario the stock is reasonable at 12-13x earnings. P/B of 1.44x is acceptable for an 11.6% ROE bank, and the 3.44% dividend yield adds support. I would not anchor on the 2.22x P/S, because this dataset's revenue line is gross/interest income rather than bank net revenue.

At the $62.40 quote as of 2026-08-27, the market is paying roughly 12x forward earnings for a company that is beating estimates and guiding revenue higher — so the stock is not pricing in a speculative acceleration. If USB delivers the roughly 13% EPS growth implied by the $5.22 forward estimate and keeps positive operating leverage, a re-rating toward 13x or above becomes plausible. If rate cuts compress NIM and fee growth cools, the low multiple offers only modest cushion, making this an execution-dependent value-plus-momentum setup.

As of 2026-08-27, RSI at 44.7 is neutral — neither oversold nor overbought. Price is 2.0% below the 20-day SMA and 0.4% below the 50-day SMA, but still 10.9% above the 200-day SMA, which reads as short-term consolidation inside a longer-term uptrend after the mid-August high near $65.63. There is no fresh momentum entry signal yet, but the 200-day cushion suggests the intermediate trend is intact; a push back above the 20-day around $63.50 would be the first positive trigger.

• Fed rate path: future rate cuts could pressure net interest income, but USB's asset-liability positioning protected NIM and NII still rose 7.7% year over year in Q2 2026.
• Treasury yield volatility and fiscal-deficit concerns: intermittent risk-off can pressure bank multiples even when fundamentals are solid.
• Regulatory capital: passing the 2026 stress test and holding a 10.8% CET1 ratio support dividends and buybacks, though future Basel changes remain an overhang.
• Credit cycle: credit quality has been stable, with commercial real estate and consumer leverage the main watch items.
• Capital-markets activity: BTIG integration adds higher-margin fee revenue and reduces dependence on pure rate-driven lending.

• Q3 2026 earnings in mid-October: the market will check whether management maintains raised revenue guidance, keeps NII growing, and controls expenses.
• Federal Reserve decisions: rate cuts or a softer landing could either squeeze NIM or support credit, lending volumes, and capital-markets activity.
• Capital return: the planned 4% dividend hike and continued buybacks are income-positive catalysts.
• Continued BTIG integration: capital-markets revenue surged 62.5% year over year in Q2 2026; further momentum would support fee-income growth.

• NIM compression if rate cuts reprice earning assets faster than deposit costs.
• Credit deterioration in commercial real estate or consumer loan portfolios.
• Tighter regulatory capital requirements than the stress-test result implies.
• Integration or operational risk from BTIG and other recent M&A.

At the $62.40 price as of 2026-08-27, USB is a solid income-plus-value investment with an improving earnings trajectory: roughly 12x forward earnings, a 3.4% dividend, expanding margins, and a diversifying fee business. The main risk is rate-driven NIM pressure rather than franchise quality, so the directional lean is bullish, but this is analysis, not personalized financial advice.

Using a justified forward P/E of 13.2x — a modest premium to USB's 5-year average of 12.04x, supported by roughly 13% forward EPS growth, margin expansion, and accelerating fee income — applied to consensus forward EPS of $5.22 gives $68.90 (5.22 × 13.2).